The Effect of Cilostazol on Rheumatoid Arthritis Patients
Status:
Recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to evaluate the effect of cilostazol on Rheumatoid Arthritis
patients. It aims to answer the questions of :
1. Will Cilostazol improve the disease severity and quality of life in Rheumatoid arthritis
patients?
2. Will Cilostazol decrease the oxidative stress, inflammation and endothelial dysfunction
in Rheumatoid arthritis patients?
Participants will be randomized into two arms either treatment or control the treatment group
will be asked to take Cilostazol 100 mg twice daily in addition to the usual DMARD
(Methotrexate , Sulfasalazine , Hydroxychloroquine or Leflunomide), while the control group
will be taking the usual DMARDs only.
Patients in both arms will be followed-up every 2 weeks through out the 6-month duration of
the study.